<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[imclone Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/imclone.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to imclone]]></description>
	<s:counts start="0" returned="20" found="26" />
	<language>en-us</language>
	<item>
		<title><![CDATA[FDA to Consider Lower Standards for Amgen and ImClone in Cancer Studies]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000494/fda-to-consider-lower-standards-for-amgen-and-imclone-in-cancer-studies/]]></link>
		<description><![CDATA[In its review of applications for ImClone's Erbitux and Amgen's Vectibix, the FDA has released a statement simultaneously frowning upon retrospective analyses of drug studies and suggesting a path for their use in new indication approvals. The statement says in part:  There are multiple examples of â€œretrospectiveâ€ or post-hoc...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 12 Dec 2008 12:47:23 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/standards.html"><![CDATA[Standards]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[BMS to Lilly re ImClone: "Thanks for the Cash, Suckers!"]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000264/bms-to-lilly-re-imclone-thanks-for-the-cash-suckers/]]></link>
		<description><![CDATA[Bristol-Myers Squibb CEO James M. Cornelius wrote this note today after the announcement that Eli Lilly and ImClone had agreed on the former's $6.5 billion, $70-a-share acquisition of the latter. Let's go through it line by line to see if there's a subtext, shall we?    After describing...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 06 Oct 2008 10:06:06 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/translation.html"><![CDATA[Translation]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">BMY,LLY</category>
	</item>
	<item>
		<title><![CDATA[The Lilly-ImClone Deal Worst-Case Scenario]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000255/the-lilly-imclone-deal-worst-case-scenario/]]></link>
		<description><![CDATA[Some people were apparently surprised that Eli Lilly has emerged as the mystery $70-a-share bidder for ImClone. BNET readers weren't among them, as I noted a few days ago this is just the kind of bold plan that CEO John Lechleiter seems to favor.    Interestingly, ImClone's stock...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 02 Oct 2008 09:57:44 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asset.html"><![CDATA[Asset]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/asset+management.html"><![CDATA[Asset Management]]></category>
		<category domain="http://resources.bnet.com/topic/operational+planning.html"><![CDATA[Operational Planning]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: ImClone Takeover Drama, Generic Thalidomide, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000243/pharma-roundup-imclone-takeover-drama-generic-thalidomide-and-more/]]></link>
		<description><![CDATA[Imclone and BMS squabble over the latter's hostile takeover bid; generic thalidomide enters approval process; lack of interest shutters Boston program offering Canadian drugs to employees; Genentech VP offers tips to biotech managers. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 26 Sep 2008 16:48:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/boston.html"><![CDATA[Boston]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma's Deal-Making Frenzy: Lots of Noise, Less Substance]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000212/pharmas-deal-making-frenzy-lots-of-noise-less-substance/]]></link>
		<description><![CDATA[Reading the mainstream press over the last few weeks could give you the strong impression that pharma has entered a phase of deal-making frenzy. Here's how Reuters describes it today:  Big pharmaceutical companies are set to step up the hunt for assets to buy in promising fields like biotechnology,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 11 Sep 2008 11:34:50 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/mystery+bidder.html"><![CDATA[Mystery Bidder]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_10/ai_n19505849]]></link>
		<description><![CDATA[NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has signed settlement and sublicensing agreements with the Massachusetts Institute of Technology MIT and Repligen Corporation to end litigation related to U.S. Patent No. 4,663,281, which is owned by MIT and exclusively licensed to Repligen. All terms of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/lawsuit.html"><![CDATA[lawsuit]]></category>
		<category domain="http://resources.bnet.com/topic/massachusetts+institute+of+technology.html"><![CDATA[Massachusetts Institute of Technology]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/repligen+corp..html"><![CDATA[Repligen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
		<category domain="tickers">IMCL,RGEN</category>
	</item>
	<item>
		<title><![CDATA[Defence rests in Martha Stewart case]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200402/ai_kepm383499]]></link>
		<description><![CDATA[NEW YORK AFP ? Martha Stewart's defence team rested after calling a sole witness in the high-profile securities fraud case involving the multi-millionaire American lifestyle guru.  Stewart herself did not take the witness stand, with her lawyers seemingly keen to indicate to the jury that federal prosecutors had failed...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 25 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/witness.html"><![CDATA[witness]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Prosecution rests in Martha Stewart case]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200402/ai_kepm380521]]></link>
		<description><![CDATA[NEW YORK AFP ? The prosecution rested in the high-profile securities fraud case involving multi-millionaire American lifestyle guru Martha Stewart.  After almost four weeks of testimony from some 20 witnesses, Stewart's lawyers will now get their turn to defend their client, accused of acting on an improper tip when...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 20 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[New plan to keep biotech firms from talking out of school: FDA will watch what companies say during pre-market review process]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5247/is_7_25/ai_n29072042]]></link>
		<description><![CDATA[The Food and Drug Administration and the Securities and Exchange Commission have adopted a new plan to ensure public biotechnology companies tell their investors the truth about their dealings with the FDA.  The initiative, first unveiled Feb. 5, calls for FDA employees to report companies that spread false and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 16 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Jurors hear taped inquiry of Stewart's former broker]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmusa/is_200402/ai_kepm372961]]></link>
		<description><![CDATA[NEW YORK -- Jurors in the trial of Martha Stewart finally heard the voice of Stewart's co-defendant Wednesday, when prosecutors played a recording of testimony that Stewart's former broker, Peter Bacanovic, gave to the Securities and Exchange Commission two years ago.  Bacanovic told SEC investigators in February 2002 that...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/juror.html"><![CDATA[juror]]></category>
		<category domain="http://resources.bnet.com/topic/prosecutor.html"><![CDATA[prosecutor]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Stewart's assistant breaks down during testimony]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmusa/is_200402/ai_kepm372786]]></link>
		<description><![CDATA[NEW YORK -- Martha Stewart's personal assistant broke down in tears on the witness stand Monday as a prosecutor zeroed in on the events of Dec. 27, 2001, the day Stewart made her controversial sale of ImClone stock.  Ann Armstrong, Stewart's personal assistant since 1998, had already told the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 10 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/attorney.html"><![CDATA[attorney]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merrill+lynch+%2526+co.+inc..html"><![CDATA[Merrill Lynch & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/prosecutor.html"><![CDATA[prosecutor]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MER</category>
		<category domain="tickers">MER</category>
	</item>
	<item>
		<title><![CDATA[Former Broker's Assistant Testifies that Stewart Used Insider Stock Tip.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200402/ai_n22110367]]></link>
		<description><![CDATA[By Greg B. Smith, Daily News, New York Knight Ridder/Tribune  Business News    Feb. 5--The star witness in the Martha Stewart trial lived up to  his  billing yesterday, testifying that the domestic diva used an  illegal insider  stock tip to sell off all...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 05 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Government to Work to Stop Distribution of Bad Information from Biotech Firms.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200402/ai_n22110497]]></link>
		<description><![CDATA[By Terri Somers, The San Diego Union-Tribune Knight Ridder/Tribune  Business News    Feb. 5--The Securities and Exchange Commission and the Food and  Drug  Administration will unveil a plan today to work together to crack  down on the  dissemination of false and misleading information...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 05 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[agency]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Broker says Martha Stewart sold stock after inside tip]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200402/ai_kepm365892]]></link>
		<description><![CDATA[NEW YORK AFP ? The star witness against lifestyle guru Martha Stewart admitted he gave her an illegal tip before she dumped her holding in biotech firm ImClone.  Former Merrill Lynch broker's assistant Douglas Faneuil delivered the most damaging testimony yet against Stewart.  The high-profile businesswoman is accused...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 04 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/founder.html"><![CDATA[founder]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merrill+lynch+%2526+co.+inc..html"><![CDATA[Merrill Lynch & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MER</category>
		<category domain="tickers">MER</category>
	</item>
	<item>
		<title><![CDATA[Faneuil describes ImClone stock sales]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmusa/is_200402/ai_kepm373749]]></link>
		<description><![CDATA[NEW YORK -- After almost a full week of testimony in the trial of Martha Stewart, government prosecutors finally produced a witness who testified to direct involvement in a crime allegedly committed by her Merrill Lynch broker, Peter Bacanovic.  Douglas Faneuil, Bacanovic's former assistant, took the stand Tuesday afternoon,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 04 Feb 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/accountant.html"><![CDATA[accountant]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merrill+lynch+%2526+co.+inc..html"><![CDATA[Merrill Lynch & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/prosecutor.html"><![CDATA[prosecutor]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MER</category>
		<category domain="tickers">MER</category>
	</item>
	<item>
		<title><![CDATA[Trial begins for US homemaking icon Martha Stewart]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200401/ai_kepm356898]]></link>
		<description><![CDATA[NEW YORK AFP ? American lifestyle entrepreneur Martha Stewart arrived in federal court as the final phase of jury selection got underway for her trial on charges of securities fraud and obstruction of justice.  Stewart, 62, looked grim as she walked through a phalanx of photographers into the Manhattan...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 20 Jan 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/entrepreneurship.html"><![CDATA[Entrepreneurship]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/manhattan.html"><![CDATA[Manhattan]]></category>
		<category domain="http://resources.bnet.com/topic/obstruction.html"><![CDATA[obstruction]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Charges against Martha Stewart Are Unusual, Not Unprecedented.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200306/ai_n22211428]]></link>
		<description><![CDATA[By Greg B. Smith, Daily News, New York Knight Ridder/Tribune  Business News    Jun. 15--Two days before Martha Stewart was charged with lying to  the  feds about her sale of ImClone stock, regulators quietly nailed  another  executive for ImClone insider trading.  ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 15 Jun 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ImClone's Founder Is Sentenced to Prison Just as Cancer Drug Nears Approval.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200306/ai_n22178064]]></link>
		<description><![CDATA[By Randi F. Marshall, Newsday, Melville, N.Y. Knight Ridder/Tribune  Business News    Jun. 11--Nearly 20 years ago, brothers Samuel and Harlan Waksal  founded a  small biotechnology company with the dream of finding a  miracle cancer drug.    Now that a potentially effective...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 11 Jun 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/manhattan.html"><![CDATA[Manhattan]]></category>
		<category domain="http://resources.bnet.com/topic/newsday.html"><![CDATA[Newsday]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">IMCL</category>
	</item>
	<item>
		<title><![CDATA[Martha Stewart Resigns as Chairwoman, Chief Executive of Firm after Indictment.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200306/ai_n22155956]]></link>
		<description><![CDATA[By Greg B. Smith, Daily News, New York Knight Ridder/Tribune  Business News    Jun. 5--Martha Stewart is under indictment and out of a job.    Hours after she pleaded not guilty yesterday to a nine-count  federal  indictment, her company announced Stewart's resignation as...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 05 Jun 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Stocks Are Still on Roar.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200305/ai_n22139597]]></link>
		<description><![CDATA[By Eric Herman, Daily News, New York Knight Ridder/Tribune Business  News    May 31--Stocks continued to rocket higher yesterday, propelled by  reports  of improved consumer confidence and manufacturing, bringing the  markets to  their third straight month of gains.    The Dow...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 31 May 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/the+dow+chemical+co..html"><![CDATA[The Dow Chemical Co.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
		<category domain="tickers">NDAQ,DOW</category>
	</item>
</channel>
</rss>
